Christine Poon

Christine A. Poon currently works at The Prudential Variable Contract Real Property Account, as Director, Regeneron Pharmaceuticals, Inc., as Lead Independent Director, Neurocrine Biosciences, Inc., as Independent Director from 2023, Prudential Financial, Inc., as Independent Director from 2023, Crane Group Co., as Director from 2014, and The Prudential Insurance Company of America, Inc., as Director from 2006.
Ms. Poon also formerly worked at Johnson & Johnson, as Vice Chairman from 2005 to 2009, Koninklijke Philips NV, as Vice Chairman-Supervisory Board & Secretary from 2009 to 2021, Royal Philips Electronics USA, as Vice Chairman, The Fox Chase Cancer Center, as Director, Decibel Therapeutics, Inc., as Independent Director from 2019 to 2021, The Sherwin-Williams Co., as Independent Director from 2014 to 2025, Bristol Myers Squibb Co., as President-International Medicines from 1997 to 2000, and Fisher College of Business, as Professor from 2014 to 2015.
Ms. Poon received her Masters Business Admin degree from Boston University, undergraduate degree from Northwestern University, and graduate degree from St. Louis University.